Read Our Latest Whitepaper Here

A high-throughput proximal tubule-on-a-chip model using RPTEC cells and fluid flow to evaluate drug-induced nephrotoxicity and transporter interactions—offering a predictive, automatable platform for early-stage kidney safety assessment.

A novel Bronchus-on-a-Chip platform that mimics tubular airway architecture and supports air exposure, enabling realistic studies of mucus hypersecretion and airway remodeling in inflammatory respiratory diseases.

A multi-model GBM-on-a-chip platform replicating the human tumor microenvironment to study how glioblastoma disrupts the blood-brain barrier, alters vascular dynamics, and modulates immune signaling using patient-derived spheroids and vascularized systems.

A scalable, automation-compatible CIPN-on-a-chip model using iPSC-derived motor neurons to assess chemotherapy-induced neurotoxicity—enabling dose- and time-dependent evaluation for safer cancer treatment development.

A high-throughput liver-on-a-chip model that mimics the human liver microenvironment to predict drug-induced and AAV-mediated toxicity, integrating vascularized 3D liver tissue with immune components for scalable and automated safety screening.

A vessel-cancer co-culture microfluidic model that replicates the tumor microenvironment to assess CAR-T cell migration, infiltration, and cytotoxicity—enabling dynamic, high-throughput evaluation of immunotherapy candidates in solid tumors.